|
|
||||||||
The Journal of Immunology, Vol 147, Issue 6 1863-1868, Copyright © 1991 by American Association of Immunologists
ARTICLES |
MD Hulett, N Osman, IF McKenzie and PM Hogarth
Austin Research Institute, Austin Hospital, Heidelberg Victoria, Australia.
Chimeric Fc gamma R have been generated between the mouse high affinity receptor for IgG (Fc gamma RI) and the low affinity receptor for IgG (Fc gamma RII) by exchanging the first two domains of the three-domain extracellular structure of Fc gamma RI with the homologous two-domain extracellular structure of Fc gamma RII. Studies of the affinity and specificity of binding of mouse Ig classes to these receptors defined functional regions of Fc gamma RI and showed some surprising results. After removal of the third extracellular domain of Fc gamma RI, the remaining two domains (domains 1 and 2) retained the capacity to bind Ig in the form of immune complexes, however, they bound monomeric IgG2a with a reduced affinity. Surprisingly, these two domains in the absence of the third domain bound not only IgG2a but also IgG1 and IgG2b, i.e., the third domain of Fc gamma RI suppresses the intrinsic capacity of the first two domains to act as a low affinity Fc gamma RII-like molecule. Linking the third extracellular domain of Fc gamma RI to the two extracellular domains of Fc gamma RII resulted in a receptor that retained the specificity and affinity of Fc gamma RII. Thus, the removal of domain 3 from Fc gamma RI resulted in the conversion of Fc gamma RI to an "Fc gamma RII-like" receptor. These findings indicate that domains 1 and 2 of Fc gamma RI form an Ig-binding motif, and although domain 3 is not essential for Fc binding by Fc gamma RI, it plays a crucial role in determining the specific high affinity interaction of Fc gamma RI with IgG2a.
This article has been cited by other articles:
![]() |
P. S. Tan, A. L. Gavin, N. Barnes, D. W. Sears, D. Vremec, K. Shortman, S. Amigorena, P. L. Mottram, and P. M. Hogarth Unique Monoclonal Antibodies Define Expression of Fc{gamma}RI on Macrophages and Mast Cell Lines and Demonstrate Heterogeneity Among Subcutaneous and Other Dendritic Cells J. Immunol., March 1, 2003; 170(5): 2549 - 2556. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Atalay, A. Zimmermann, M. Wagner, E. Borst, C. Benz, M. Messerle, and H. Hengel Identification and Expression of Human Cytomegalovirus Transcription Units Coding for Two Distinct Fc{gamma} Receptor Homologs J. Virol., July 29, 2002; 76(17): 8596 - 8608. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Talkington and S. P. Nickell Role of Fc Gamma Receptors in Triggering Host Cell Activation and Cytokine Release by Borrelia burgdorferi Infect. Immun., January 1, 2001; 69(1): 413 - 419. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Fossati-Jimack, A. Ioan-Facsinay, L. Reininger, Y. Chicheportiche, N. Watanabe, T. Saito, F. M. A. Hofhuis, J. E. Gessner, C. Schiller, R. E. Schmidt, et al. Markedly Different Pathogenicity of Four Immunoglobulin G Isotype-Switch Variants of an Antierythrocyte Autoantibody Is Based on Their Capacity to Interact In Vivo with the Low-Affinity Fc{gamma} Receptor III J. Exp. Med., April 10, 2000; 191(8): 1293 - 1302. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Wernersson, M. C. I. Karlsson, J. Dahlstrom, R. Mattsson, J. S. Verbeek, and B. Heyman IgG-Mediated Enhancement of Antibody Responses Is Low in Fc Receptor {gamma} Chain-Deficient Mice and Increased in Fc{gamma}RII-Deficient Mice J. Immunol., July 15, 1999; 163(2): 618 - 622. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. D. Hulett, R. I. Brinkworth, I. F. C. McKenzie, and P. M. Hogarth Fine Structure Analysis of Interaction of Fcepsilon RI with IgE J. Biol. Chem., May 7, 1999; 274(19): 13345 - 13352. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Arita, H. Horie, M. Arita, and A. Nomoto Interaction of Poliovirus with Its Receptor Affords a High Level of Infectivity to the Virion in Poliovirus Infections Mediated by the Fc Receptor J. Virol., February 1, 1999; 73(2): 1066 - 1074. [Abstract] [Full Text] |
||||
![]() |
A. L. Gavin, N. Barnes, H. M. Dijstelbloem, and P. M. Hogarth Cutting Edge: Identification of the Mouse IgG3 Receptor: Implications for Antibody Effector Function at the Interface Between Innate and Adaptive Immunity J. Immunol., January 1, 1998; 160(1): 20 - 23. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. L. Gavin, J. A. Hamilton, and P. M. Hogarth Extracellular Mutations of Non-obese Diabetic Mouse Fcgamma RI Modify Surface Expression and Ligand Binding J. Biol. Chem., July 19, 1996; 271(29): 17091 - 17099. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. L. Shields, A. K. Namenuk, K. Hong, Y. G. Meng, J. Rae, J. Briggs, D. Xie, J. Lai, A. Stadlen, B. Li, et al. High Resolution Mapping of the Binding Site on Human IgG1 for Fcgamma RI, Fcgamma RII, Fcgamma RIII, and FcRn and Design of IgG1 Variants with Improved Binding to the Fcgamma R J. Biol. Chem., February 23, 2001; 276(9): 6591 - 6604. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |